Chapter 1. Research Background
1.1. Research Objectives
1.2. Market Definition
1.3. Research Scope
1.3.1. Market Segmentation by Type of Drug
1.3.2. Market Segmentation by Application
1.3.3. Market Segmentation by End User
1.3.4. Market Segmentation by Geography
1.3.5. Analysis Period
1.3.6. Market Data Reporting Unit
1.3.6.1. Value
1.4. Key Stakeholders
Chapter 2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.2.1. Breakdown of Primary Research Respondents
2.2.1.1. By region
2.2.1.2. By industry participants
2.2.1.3. By company type
2.3. Market Size Estimation
2.4. Market Breakdown and Data Triangulation
2.5. Assumptions for the Study
Chapter 3. Executive Summary
Chapter 4. Introduction
4.1. Market Segmentation
4.1.1. Overview by Type of Drug
4.1.1.1. Baclofen
4.1.1.2. Hydromorphone
4.1.1.3. Morphine
4.1.1.4. Clonidine
4.1.1.5. Midazolam
4.1.1.6. Bupivacaine
4.1.1.7. Others
4.1.2. Overview by Application
4.1.2.1. Pain management
4.1.2.2. Spasticity management
4.1.3. Overview by End User
4.1.3.1. Hospitals
4.1.3.2. Clinics
4.1.3.3. Others
4.2. Value Chain Analysis
4.3. Market Dynamics
4.3.1. Trends
4.3.2. Drivers
4.3.2.1. Impact analysis of drivers on market forecast
4.3.3. Restraints
4.3.3.1. Impact analysis of restraints on market forecast
4.3.4. Opportunities
4.4. Porter’s Five Forces Analysis
Chapter 5. Market Size and Forecast by Type of Drug
5.1. Baclofen
5.2. Hydromorphone
5.3. Morphine
5.4. Clonidine
5.5. Midazolam
5.6. Bupivacaine
5.7. Others
Chapter 6. Market Size and Forecast by Application
6.1. Pain Management
6.2. Spasticity Management
Chapter 7. Market Size and Forecast by End User
7.1. Hospitals
7.2. Clinics
7.3. Others
Chapter 8. Market Size and Forecast by Geography
8.1. North America Intrathecal Pumps Market
8.1.1. By Type of Drug
8.1.2. By Application
8.1.2.1. Pain management, by number of procedures
8.1.2.2. Spasticity management, by number of procedures
8.1.3. By End User
8.1.4. By Country – The U.S. and Canada
8.2. Europe Intrathecal Pumps Market
8.2.1. By Type of Drug
8.2.2. By Application
8.2.2.1. Pain management, by number of procedures
8.2.2.2. Spasticity management, by number of procedures
8.2.3. By End User
8.2.4. By Country – The U.K., Germany, France, Italy, Spain and Rest of Europe
8.3. Asia-Pacific Intrathecal Pumps Market
8.3.1. By Type of Drug
8.3.2. By Application
8.3.2.1. Pain management, by number of procedures
8.3.2.2. Spasticity management, by number of procedures
8.3.3. By End User
8.3.4. By Country – Japan, China, India and Rest of Asia-Pacific
8.4. Latin America Intrathecal Pumps Market
8.4.1. By Type of Drug
8.4.2. By Application
8.4.2.1. Pain management, by number of procedures
8.4.2.2. Spasticity management, by number of procedures
8.4.3. By End User
8.4.4. By Country – Brazil and Rest of Latin America
8.5. Middle East & Africa Intrathecal Pumps Market
8.5.1. By Type of Drug
8.5.2. By Application
8.5.2.1. Pain management, by number of procedures
8.5.2.2. Spasticity management, by number of procedures
8.5.3. End User
Chapter 9. Competitive Landscape
9.1. Competitive Analysis of Key Players
9.2. Global Strategic Developments
Chapter 10. Company Profiles
10.1. Codman & Shurtleff, Inc.
10.1.1. Business Overview
10.1.2. Product and Service Offerings
10.1.3. Strategic Growth Plan
10.2. Medtronic PLC
10.2.1. Business Overview
10.2.2. Product and Service Offerings
10.2.3. Strategic Growth Plan
10.3. Arrow International, Inc.
10.3.1. Business Overview
10.3.2. Product and Service Offerings
10.3.3. Strategic Growth Plan
10.4. Medallion Therapeutics, Inc.
10.4.1. Business Overview
10.4.2. Product and Service Offerings
10.4.3. Strategic Growth Plan
10.5. Flowonix, Inc.
10.5.1. Business Overview
10.5.2. Product and Service Offerings
10.5.3. Strategic Growth Plan
10.6. Tricumed Medizintechnik GmbH
10.6.1. Business Overview
10.6.2. Product and Service Offerings
10.6.3. Strategic Growth Plan
10.7. Johnson & Johnson
10.7.1. Business Overview
10.7.2. Product and Service Offerings
10.7.3. Strategic Growth Plan
10.8. Smiths Group PLC
10.8.1. Business Overview
10.8.2. Product and Service Offerings
10.8.3. Strategic Growth Plan
10.9. Summit Medical Products Inc.
10.9.1. Business Overview
10.9.2. Product and Service Offerings
10.9.3. Strategic Growth Plan
10.10. Becton, Dickinson and Company
10.10.1. Business Overview
10.10.2. Product and Service Offerings
10.10.3. Strategic Growth Plan
*Note: Strategic growth plan will be provided on best effort basis and is subject to availability during primary and secondary research.
Chapter 11. Appendix
11.1. Abbreviations
